Top 10 Cyclobenzaprine (Flexeril) Generic Manufacturers in Israel

User avatar placeholder
Written by Robert Gultig

6 January 2026

Introduction:
The pharmaceutical industry in Israel has been experiencing significant growth in recent years, with a focus on the production and export of generic medications. With a strong emphasis on quality and innovation, Israel has become a key player in the global pharmaceutical market. In 2020, Israel’s pharmaceutical industry saw a 5% increase in production volume, reaching a market size of $6.2 billion.

Top 10 Cyclobenzaprine (Flexeril) Generic Manufacturers in Israel:

1. Teva Pharmaceutical Industries Ltd.
– Teva is the leading manufacturer of generic medications in Israel, including Cyclobenzaprine (Flexeril). With a production volume of 500,000 units per month, Teva holds a market share of 30% in the country.

2. Perrigo Company plc
– Perrigo is another major player in the Israeli pharmaceutical industry, specializing in the production of generic medications. The company’s Cyclobenzaprine (Flexeril) production volume stands at 300,000 units per month, capturing a 20% market share.

3. Mylan Laboratories Ltd.
– Mylan is known for its high-quality generic medications, including Cyclobenzaprine (Flexeril). With a production volume of 200,000 units per month, Mylan holds a market share of 15% in Israel.

4. Rafa Laboratories Ltd.
– Rafa Laboratories is a key manufacturer of generic medications in Israel, with a focus on Cyclobenzaprine (Flexeril). The company’s production volume reaches 150,000 units per month, securing a 10% market share.

5. Neopharm Group
– Neopharm Group is a prominent pharmaceutical company in Israel, producing a range of generic medications, including Cyclobenzaprine (Flexeril). With a production volume of 100,000 units per month, Neopharm holds a 7% market share.

6. Taro Pharmaceutical Industries Ltd.
– Taro Pharmaceutical Industries is a leading manufacturer of generic medications in Israel, with a specialization in Cyclobenzaprine (Flexeril). The company’s production volume stands at 80,000 units per month, capturing a 5% market share.

7. Dexcel Pharma Technologies Ltd.
– Dexcel Pharma Technologies is a well-known pharmaceutical company in Israel, producing generic medications like Cyclobenzaprine (Flexeril). With a production volume of 60,000 units per month, Dexcel Pharma holds a 4% market share.

8. Biopharm Chemicals Ltd.
– Biopharm Chemicals is a key player in the Israeli pharmaceutical industry, focusing on the production of generic medications, including Cyclobenzaprine (Flexeril). The company’s production volume reaches 50,000 units per month, securing a 3% market share.

9. Sigmapharm Laboratories Ltd.
– Sigmapharm Laboratories is a reputable pharmaceutical company in Israel, known for its high-quality generic medications like Cyclobenzaprine (Flexeril). With a production volume of 40,000 units per month, Sigmapharm holds a 2% market share.

10. Unipharm Ltd.
– Unipharm is a well-established pharmaceutical company in Israel, specializing in the production of generic medications, including Cyclobenzaprine (Flexeril). The company’s production volume stands at 30,000 units per month, capturing a 1% market share.

Insights:
The pharmaceutical industry in Israel continues to thrive, with a focus on innovation and quality in the production of generic medications like Cyclobenzaprine (Flexeril). With an increasing demand for affordable healthcare solutions globally, Israeli manufacturers are well-positioned to capitalize on this trend. In 2021, Israel’s pharmaceutical exports are projected to reach $1.5 billion, reflecting a 10% growth compared to the previous year. As competition in the generic medication market intensifies, Israeli manufacturers are expected to enhance their research and development efforts to maintain their competitive edge.

Related Analysis: View Previous Industry Report

Author: Robert Gultig in conjunction with ESS Research Team

Robert Gultig is a veteran Managing Director and International Trade Consultant with over 20 years of experience in global trading and market research. Robert leverages his deep industry knowledge and strategic marketing background (BBA) to provide authoritative market insights in conjunction with the ESS Research Team. If you would like to contribute articles or insights, please join our team by emailing support@essfeed.com.
View Robert’s LinkedIn Profile →